BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Saturday, February 14, 2026
Breaking News: BioWorld Science 2025 Year in Review
See today's BioWorld Science
Home
» Whitehawk announces IND progress for HWK-007, HWK-016
To read the full story,
subscribe
or
sign in
.
Immuno-oncology
Whitehawk announces IND progress for HWK-007, HWK-016
Jan. 9, 2026
No Comments
Whitehawk Therapeutics Inc. has obtained IND clearance from the FDA for HWK-007, its PTK7-targeted antibody-drug conjugate (ADC).
BioWorld Science
Regulatory
Cancer
Antibody-drug conjugate
Immuno-oncology
FDA
IND
